أعرض في EDS

Effectiveness, Safety, and Patient-Reported Outcomes (PROs) in Patients With Hereditary Angioedema (HAE) From the United States and Canada Treated With Lanadelumab: 24-Month Data From the EMPOWER Study

التفاصيل البيبلوغرافية
العنوان: Effectiveness, Safety, and Patient-Reported Outcomes (PROs) in Patients With Hereditary Angioedema (HAE) From the United States and Canada Treated With Lanadelumab: 24-Month Data From the EMPOWER Study
المؤلفون: H. James Wedner, Jonathan Bernstein, Stephen Betschel, Michael Manning, Daniel Nova Estepan, Kezhen Fei, Ashley Yegin, Maureen Watt, Sunetra Chavan, Paula Busse
المصدر: Journal of Allergy and Clinical Immunology. 151:AB131
بيانات النشر: Elsevier BV, 2023.
سنة النشر: 2023
مصطلحات موضوعية: Immunology, Immunology and Allergy
تدمد: 0091-6749
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::66985f3ecd2f9c363f5cf6e2a86166dd
https://doi.org/10.1016/j.jaci.2022.12.413
حقوق: CLOSED
رقم الأكسشن: edsair.doi...........66985f3ecd2f9c363f5cf6e2a86166dd
قاعدة البيانات: OpenAIRE
الوصف
تدمد:00916749